✅ 10 criteria passed
❌ 1 criteria to solve
Boost keytruda.com's SEO with Kontactr's Guest Posting.
Secure high-authority, do-follow backlinks from our trusted site—DA45 domain authority and PA55 homepage and blog pages.
Perfect for webmasters seeking higher search rankings and increased organic traffic.
Simple, quick, and effective.
opens a new window
KEYTRUDA® (pembrolizumab)
https://keytruda.com
Learn about how KEYTRUDA® (pembrolizumab) works as an anti-PD-1 immunotherapy to help fight certain cancers.
https://keytruda.com
KEYTRUDA® (pembrolizumab)
Learn about how KEYTRUDA® (pembrolizumab) works as an anti-PD-1 immunotherapy to help fight certain cancers.
Great, a redirect is in place to redirect traffic from your non-preferred domain. All versions of your page point to the same URL.
| Attribute | Value |
| ⓘ viewport | width=device-width, initial-scale=1.0 |
ⓘ The owner has associated the following topics to the website.
ⓘ The results of our semantic analysis are shown below using the website's language.
They are the main concepts covered by keytruda.com.
Each concept has a confidence score. The higher it is, the more important the topic is relative to the page.
| Topics | |
Pembrolizumab Confidence: 95% 
|
|
Immunotherapy Confidence: 88%
|
|
Programmed cell death protein 1 Confidence: 84%
|
|
Cancer Confidence: 74%
|
✅ keytruda.com website speed is normal. Page speed is important for visitors and search engines.
Get insights to improve your page loading time.
This domain loads at the median speed of 0.6 seconds.
keytruda.com is faster than approximately 94 percent of the web. Your website page speed needs to be as fast as you can make it, without compromising the customer experience.
A good goal to achieve is a loading time of 2 seconds on desktop and mobile devices.
ⓘ This website is ranked #328.464 by Alexa.
This rank is traffic based. The lower the rank is, the better the domain is ranked.
| Country | Rank |
 United States of America |
#87.560 |
Mobile Rendering
This website seems to be optimized for Mobile Visitors.
Phone
Tablet
A good text to HTML ratio is anywhere from 25 to 70%.
This percentage refers to the visible text ratio, as opposed to HTML elements, image tags and other non-visible information.
Great, we found headings on this page.
| Top level heading |
| An ımmunotherapy that may help fıght your cancer. ıt’s tru. keytruda. an ımmunotherapy that may help fıght your cancer. ıt’s tru. keytruda. |
| 2nd level heading |
| Tru patıent storıes |
| How keytruda works |
| Questıons about ınsurance coverage or fınancıal assıstance? wecanhelp |
| 3rd level heading |
| Learn more about the key+you patıent support program |
| 5th level heading |
| ımportant safety ınformation about keytruda®(pembrolizumab) (2) |
| See full indications |
We found 10 images on this website.
3
ALT attributes are missing on your image tags. The issue affects 2 actual different images that could be loaded more than once in your page.
| Image | Image URL | Occurrences |
 |
/static/images/hcc-opt-keytruda-logo.svg | 2 |
 |
/static/images/hcc-opt-icn_tooltip-close.svg | 1 |
Alternative text allows you to add a description to an image.
Google rely on alternative text attributes to determine relevance to a search query. Alternative text also makes an image more likely to appear in a Google image search.
It looks like you're missing alternative text for 3 images on keytruda.com. Check your website to make sure it's specified for each image on the page.
For a better readability, only the first 50 internal links are shown below.
| Anchor | Type | URL |
| Back to KEYTRUDA | text | / |
| For Health Care Professionals | text | /hcp/ |
| MENU | text | menu/ |
| Important Safety Information | text | /important-safety-information/ |
| Health Care Professionals Site | text | https://www.keytruda.com/hcp/ |
 |
image | / |
| Menu | text | menu/ |
| How KEYTRUDA works | text | /how-does-keytruda-work/ |
| Side effects | text | /side-effects/ |
| Taking KEYTRUDA | text | /taking-keytruda/ |
| Support and coverage | text | /keytruda-patient-support-program/ |
| | text | / |
| ADVANCED NON–SMALL CELL LUNG CANCER | text | /non-small-cell-lung-cancer/ |
| MELANOMA | text | /melanoma/ |
| HEAD AND NECK SQUAMOUS CELL CANCER | text | /head-and-neck-cancer/ |
| ADVANCED UROTHELIAL BLADDER CANCER | text | /advanced-urothelial-bladder-cancer/ |
| ADVANCED KIDNEY CANCER (RCC) | text | /advanced-kidney-cancer/ |
| MICROSATELLITE INSTABILITY-HIGH CANCER | text | /msi-h/ |
| CLASSICAL HODGKIN LYMPHOMA | text | /classical-hodgkin-lymphoma/ |
| ADVANCED GASTRIC CANCER | text | /gastric-cancer/ |
| ADVANCED CERVICAL CANCER | text | /cervical-cancer/ |
| PRIMARY MEDIASTINAL B‑CELLLYMPHOMA | text | /primary-mediastinal-b-cell-lymphoma/ |
| ADVANCED HEPATOCELLULAR CARCINOMA | text | /advanced-hepatocellular-liver-cancer/ |
| ADVANCED MERKEL CELL CARCINOMA | text | /merkel-cell-carcinoma/ |
| ADVANCED ESOPHAGEAL SQUAMOUS CELL CARCINOMA | text | /esophageal-cancer/ |
 |
image | /non-small-cell-lung-cancer/patient-stories/ |
 |
image | /melanoma/patient-stories/eriks-story/ |
| Go to patient stories | text | /patient-stories/ |
 |
image | /how-does-keytruda-work/ |
| works with your immune system to help fight cancer | text | /keytruda-faq/is-keytruda-an-immunotherapy/ |
| Learn more about how KEYTRUDA works | text | /how-does-keytruda-work/ |
| Learn more about patient support | text | /keytruda-patient-support-program/ |
 |
image | tel:+18552573932 |
| Learn about The Merck Access Program | text | /keytruda-patient-support-program/ |
| See full menu for KEYTRUDA | text | /menu/ |
| non–small cell lung cancer | text | /non-small-cell-lung-cancer/ |
| PD-L1 | text | /keytruda-faq/what-are-pd1-and-pdl1/ |
| PD‑L1 | text | /keytruda-faq/what-are-pd1-and-pdl1/ |
| urothelial carcinoma | text | /advanced-urothelial-bladder-cancer/ |
| advanced urothelial cancer | text | /advanced-urothelial-bladder-cancer/ |
| head and neck squamous cell cancer | text | /head-and-neck-cancer/ |
| PD‑L1 | text | https://www.keytruda.com/keytruda-faq/what-are-pd1-and-pdl1 |
| classical Hodgkin lymphoma | text | /classical-hodgkin-lymphoma/ |
| cervical cancer | text | /cervical-cancer/ |
| hepatocellular carcinoma | text | /advanced-hepatocellular-liver-cancer/ |
| (advanced gastric cancer) | text | /gastric-cancer/ |
| microsatellite instability-high | text | /msi-h/ |
| MSI‑H | text | /msi-h/ |
| dMMR | text | /msi-h/ |
| primary mediastinal B-cell lymphoma | text | /primary-mediastinal-b-cell-lymphoma/ |
| Anchor | Type | URL |
| Medication Guide | text | http://www.merck.com/product/usa/pi_circulars/k/keytruda/keytruda_mg.pdf |
| Prescribing Information | text | http://www.merck.com/product/usa/pi_circulars/k/keytruda/keytruda_pi.pdf |
| Privacy Policy | text | http://www.merck.com/about/how-we-operate/privacy/internet-privacy-policy.html |
| Terms of Use | text | http://www.merck.com/policy/terms-of-use/home.html |
| ⓘ Domain Registrar | MARKMONITOR, INC. |
| ⓘ Registration Date | 11/11/2011 13 years, 7 days ago |
| ⓘ Last Modified | 10/11/2018 6 years, 1 month, 7 days ago |
| ⓘ Expiration Date | 11/11/2020 Expired |
| Host | IP Address | Country |
| ns-439.awsdns-54.com | 205.251.193.183 | United States |
| ns-793.awsdns-35.net | 205.251.195.25 | United States |
| ns-1162.awsdns-17.org | 205.251.196.138 | United States |
| ns-1662.awsdns-15.co.uk | 205.251.198.126 | United States |
Others (37.9%)
SOCIAL MEDIA PRESENCE
You have a relatively high presence on social media, keep going!
The more people share your website, the more likely you will get links from others, which is a key point when it comes to improving your overall search engine rankings.